The FDA Just Approved a New Depression Treatment—and It Doesn’t Involve Medication

Known as transcranial direct-current stimulation, or tDCS, the technology is designed for at-home use, potentially offering a more accessible alternative to traditional therapies, according to The New York Times.
STAT

Katherine Szarama named acting director of FDA’s vaccines and biologics center

Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.

US FDA approves Axsome's drug for Alzheimer's-related agitation

By Kamal Choudhury and Mariam Sunny April 30 (Reuters) - The U.S. Food and Drug Administration has approved Axsome Therapeutics' drug to treat agitation in patients with Alzheimer's disease, the company said on Thursday,

FDA set to pilot test real-time tracking of clinical trials

The Food and Drug Administration (FDA) is set to pilot test real-time clinical trials in the hopes of expediting results and feedback, federal health officials announced on Tuesday. At least two clinical trials by pharmaceutical companies AstraZeneca and Amgen will test the new system to alert FDA officials to study results in real time.

America's infant formula supply is safe, FDA testing confirms

The FDA tested infant formula for contaminants, finding the U.S. supply is safe, but small exposures still matter for newborns.

FDA affirms safety of infant formula from heavy metals

The U.S. infant formula supply is largely safe from contaminants, according to new testing results announced Wednesday by the Food and Drug Administration (FDA). Between 2023 and 2025, FDA purchased and tested more than 300 infant formula samples at retail stores covering 16 brands.

New Infant Formula Test Results Are Released by the FDA

The FDA has released the findings of a comprehensive test of infant formula in the U.S. CR's experts say some of the results raise questions.